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The telomerase enzymes that have been character-
Hamilton, Ontario
ized to date are RNA-dependent DNA polymerases that
Canada L8N3Z5 synthesize the telomeric DNA repeats by using an RNA
template that exists as a subunit of the telomerase holo-
enzyme (Greider, 1995). The genes specifying the RNA
subunits of telomerases have been cloned from a wideSummary
variety of species, including humans (Feng et al., 1995;
Greider, 1995), and have been shown in several in-Telomerase, the ribonucleoprotein enzyme that elon-
stances to be essential for telomerase function in vivo
gates telomeres, is repressed in normal human so-
(Yu et al., 1990; Yu and Blackburn, 1991; Singer and
matic cells but is reactivated during tumor progres- Gottschling, 1994; Cohn and Blackburn, 1995; McEa-
sion. We report the cloning of a human gene, hEST2, chern and Blackburn, 1995). In addition, three proteins
that shares significant sequence similarity with the have been identified to date that are associated with
telomerase catalytic subunit genes of lower eukary- telomerase activity. p80 and p95 were purified from the
otes. hEST2 is expressed at high levels in primary ciliate Tetrahymena (Collins et al., 1995), and the gene
tumors, cancer cell lines, and telomerase-positive tis- encoding a mammalian homolog of p80, TP1/TLP1, has
sues but is undetectable in telomerase-negative cell also been cloned (Harrington et al., 1997; Nakayama
lines and differentiated telomerase-negative tissues. et al., 1997). The specific mechanism by which these
Moreover, the message is up-regulated concomitant proteins participate in telomerase function has not been
with the activation of telomerase during the immortali- defined.
zation of cultured cells and down-regulated during Most recently, two related proteins, Est2p from the
in vitro cellular differentiation. Taken together, these yeast Saccharomyces cerevisiae and p123 from the cili-
observations suggest that the induction of hEST2 ate Euplotes aediculatus, were identified as the catalytic
mRNA expression is required for the telomerase acti- subunits of telomerase in their respective species
vation that occurs during cellular immortalization and (Counter et al., 1997; Lingner et al., 1997). EST2 was
first identified as a gene required for telomere mainte-tumor progression.
nance in yeast (Lendvay et al., 1996) and is essential for
telomerase activity (Counter et al., 1997; Lingner et al.,
Introduction 1997). Both the yeast and Euplotes proteins harbor sev-
eral sequence motifs that are hallmarks of the catalytic
The linear chromosomes of eukaryotic cells offer the regions of reverse transcriptases; substitution of several
biological advantages of rapid recombination, assort- such residues in Est2p abolishes telomerase activity
ment, and genetic diversification.However, linear DNA is (Counter et al., 1997; Lingner et al., 1997). The mamma-
inherently more unstable than circular forms. To address lian homolog of these telomerase subunits has not yet
this difficulty, the eukaryotic chromosome has evolved been reported.
to include a DNA-protein structure, the telomere, which As might be expected from the known enzymatic
properties of telomerase, perturbing the function of this
enzyme in the ciliate Tetrahymena, through the overex-
pression of an inactive form of the telomerase RNA, or# These authors contributed equally to this work.
Cell
786
in yeast, through the mutation of genes encoding either Moreover, telomerase activity is readily detected in the
great majority of human tumor samples analyzed to datethe catalytic protein or template RNA subunit, leads to
progressive telomere shortening as cells pass through (Counter et al., 1994b; Kim et al., 1994; Shay and Bac-
chetti, 1997).successive cycles of replication (Yu et al., 1990; Singer
and Gottschling, 1994; McEachern and Blackburn, 1995; Taken together, these various observationshave been
incorporated into a model that proposes that the limita-Lendvay et al., 1996; Counter et al., 1997; Lingner et al.,
1997). This loss of telomeric DNA is ultimately lethal if tion on prolonged cell replication imposed by telomere
shortening serves as an important antineoplastic mech-it is not overcome. The lethality seems to be triggered
when telomeres have been truncated below a critical anism used by the body to block the expansion of pre-
cancerouscell clones. According to such a model, tumorthreshold level. Hence, in the absence of compensating
mechanisms, yeast cell lineages that lack telomerase cells transcend the crisis barrier and emerge as immor-
talized cell populations by activating previously unex-activity have a lifespan dictated by the lengths of their
telomeres. pressed telomerase, enabling them to restore and main-
tain the integrity of their telomeres (Counter et al., 1992,In humans, telomerase activity is readily detectable
in germline cells and in certain stem cell compartments. 1994b; Harley et al., 1994).
A major question provoked by this model is the mech-However, enzyme activity is not detectable in most so-
matic cell lineages (Harley et al., 1994; Kim et al., 1994; anism used to resurrect telomerase expression during
tumor progression. Expression of the telomerase-asso-Broccoli et al., 1995; Counter et al., 1995; Hiyama et al.,
1995). Consistent with this, telomeres of most types of ciated protein TP1/TLP1 does not reflect the level of
telomerase activity (Harrington et al., 1997; Nakayamahuman somatic cells shorten with increasing organismic
age and with repeated passaging in culture, similar to et al., 1997). It is also clear that the levels of the human
telomerase RNA component, hTR, cannot completelythe situation seen in protozoan and yeast cells that have
been deprived experimentally of a functional telomerase explain the regulation of telomerase activity. Although
the levels of hTR and its mouse counterpart, mTR, in-enzyme (Harley et al., 1990; Hastie et al., 1990). Eventu-
ally, the proliferation of cultured human cells will halt at crease with tumor progression (Feng et al., 1995; Blasco
et al., 1996; Broccoli et al., 1996; Soder et al., 1997), thea point termed senescence (Hayflick and Moorhead,
1961; Goldstein, 1990), apparently before the telomeres amounts of these transcripts do not always correlate
with enzymatic activity. Indeed, hTR or mTR transcriptof these cells have become critically short.
Cultured normal human cells can circumvent senes- levels can be significantly higher in telomerase-negative
cells and tissues than in telomerase-positive cancercence and thereby continue to proliferate when trans-
formed by a variety of agents. In such cultures, telomere cells (Avilion et al., 1996; Bestilny et al., 1996; Blasco
et al., 1996). Similarly, even though telomerase levelsshortening continues until a subsequentpoint is reached
that is termed crisis, where telomeres have become increase 100- to 2000-fold during the immortalization of
human cells, the level of hTR message increases, atextremely short (Counter et al., 1992, 1994a; Shay et
al., 1993; Klingelhutz et al., 1994). Crisis, perhaps best most, two-fold (Avilion et al., 1996). Therefore, derepres-
sion of the hTR and TP1 subunits cannot easily be in-described in SV40-transformed cells, is characterized by
karyotypic instability, particularly the types of instability voked to explain the appearance of telomerase activity
in the great majority of human tumor samples. Thusobserved in chromosomes lacking functional telomeres,
and by significant levels of cell death (Sack, 1981). The far, the rate-limiting step in telomerase activation has
remained elusive.crisis phenotype is reminiscent of that observed in yeast
and Tetrahymena cells in which telomerase function has We report here the isolation of a gene that represents
the human homolog of the yeast and ciliate genes en-been experimentally perturbed.
The simplest interpretation of these data is that the coding the telomerase catalytic subunits. Evidence pre-
sented here also provides an important clue indicatinglifespan of telomerase-negative human cells, like that
of their yeast and ciliate counterparts, is ultimately lim- how telomerase activity is activated during cellular im-
mortalization and malignant tumor progression.ited by the length of telomeres. Rare human cells that
have acquired the ability to grow indefinitely emerge
from crisis populations with a frequency of 1026±1027
Results(Huschtscha and Holliday, 1983; Shayand Wright, 1989).
This implies that a mutational event is required to confer
Identification of the hEST2 Genethe immortal phenotype on these cells. The immortal
Using the sequences derived from the catalytic subunitcells that escape crisis are characterized by readily de-
of the S. cerevisiae telomerase, Est2p, and from thetectable levels of telomerase activity and by stable telo-
Euplotes p123 protein (Lendvay et al., 1996; Counter etmeres (Counter et al., 1992, 1994a; Shay et al., 1995;
al., 1997; Lingner et al., 1997), we identified a human ho-Whitaker et al., 1995; Gollahon and Shay, 1996; Klingel-
molog (GenBank accession number AA281296) in thehutz et al., 1996). This suggests that activation of telo-
National Center for Biotechnology Information expressedmerase can overcome the limitations imposed by telo-
sequence tag database. As shown in Figure 1 (under-mere length on the lifespan of cell lineages.
lined sequence), the conceptual translation of this DNAActivation of telomerase also appears to be a major
sequence shows clear relatedness to both the yeaststep in the progression of human cancers.Unlike normal
and ciliate telomerase sequences, as evidenced by iden-human cells, cancer cells can be established as perma-
tical or similar amino acid residues scattered throughoutnent cell lines and thus are presumed to have undergone
immortalization during the process of tumorigenesis. the entire length of the expressed sequence tag.
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Figure 1. hEST2 Encodes a Human Homolog of Est2p and p123
Alignment of the predicted amino acid sequence of hEST2 with the yeast Est2p and Euplotes p123 homologs. Amino residues within shaded
and closed blocks are identical between at least two proteins. Identical amino acids within the RT motifs (Poch et al., 1989; Xiong and
Eickbush, 1990) are in closed boxes, an example of a telomerase-specific motif in an outlined shaded box, and all other identical amino acids
in shaded boxes. RT motifs are extended in some cases to include other adjacent invariant or conserved amino acids. The sequence of the
expressed sequence tag AA281296 is underlined.
Since the identified expressed sequence tag provided human testis cDNA and on an independently generated
human testis cDNA library.only a fragment of the putative human telomerase open
reading frame, we screened a human Jurkat T-cell lym- Assembly of the cDNA clones and RACE products,
together with the clone containing the expressed se-phoma and a human Nalm-6 pre-B cell leukemia cDNA
library with a probe derived from the expressed se- quence tag, resulted in a contiguous sequence spanning
4030 bp. Conceptual translation of this 4 kbp sequencequence tag and retrieved a total of seven cDNA clones.
The resulting sequence was extended further in the 59 reveals an open reading frame of 1132 amino acids that
is predicted to encode a 127 kDa protein (Figure 1).direction by rapid amplification of cDNA ends (RACE) on
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Although we have not identified an in-frame upstream
stop codon in the sequence, the first methionine identi-
fied by RACE (Figure 1) is a candidate for the translation
start site, as the sequence of this putative translation
initiation site, CCCGCGAUGC, is similar to the consen-
sus GCC(A/G)CCAUGG characteristic of translation initi-
ation sites (Kozak, 1986).
The predicted 127 kDa protein shares extensive se-
quence similarity with the entire sequences of the Eu-
plotes and yeast telomerase subunits (Figure 1) and
extends beyond the amino and carboxyl termini of these
proteins. A BLAST search reveals that the probabilities
of these similarities occurring by chance are 1.3 3 10218
and 3 3 10213, respectively. By way of comparison, the
probability of similarity between the yeast and Euplotes Figure 2. Alignment of RT Motifs 1±6 of Telomerase Subunits
telomerases in a protein BLAST search is 6.9 3 1026. hEST2, p123, and Est2p with S. cerevisiae Group II Intron±Encoded
We have named the human gene hEST2 (human EST2 RTs a2-Sc and a1-Sc
homolog) to reflect its clear relationship with the yeast The consensus sequence of each RT motif is shown ([h], hydropho-
bic residues; [p], small polar residues; [c], charged residues). Aminogene, the first of these genes to be described. EST2
acids that are invariant among telomerases and the RT consensuswas named because of thephenotype of ever shortening
are in closed boxes, while those that are invariant among te-telomeres caused by its mutant alleles (Lendvay et al.,
lomerases and similar to the RT consensus are in shaded boxes.1996) and was later demonstrated to encode the yeast
Open boxes identify highly conserved residues unique to either
telomerase catalytic subunit (Counter et al., 1997; Ling- telomerases or to nontelomerase RTs. Asterisks denote amino acids
ner et al., 1997). essential for polymerase catalytic function.
Like the yeast and ciliate telomerase proteins, hEST2
is a member of the reverse transcriptase (RT) family of
enzymes (Figures 1 and 2). Seven conserved sequence Even within the hEST2 domains that share sequence
motifs, which define the polymerase domains of these similarity with RTs, it is clear that hEST2 is more closely
enzymes, are shared among the otherwise highly diver- related to the already described telomerases than it is
gent RT family (Poch et al., 1989; Xiong and Eickbush, to nontelomerase RTs. For example, the sequence simi-
1990). p123 and Est2p share six of these motifs with, larity of the region encompassing the RT motifs between
most prominently, the a2-Sc enzyme, an RT that is en- hEST2 and the catalytic subunits of yeast and Euplotes
coded within the second intron of the yeast COX1 gene has a probability of chance occurrence of 5.7 3 1026
(Kennell et al., 1993). These six motifs, including the and 1.9 3 1025, respectively, compared to 0.0056 for
invariant aspartic acid residues known to be required a2-Sc, the next most closely related nontelomerase RT.
for telomerase enzymatic function (Counter et al., 1997;
Within the RT motifs are several amino acids that are
Lingner et al., 1997), are found at the appropriate posi-
invariant among the telomerases but divergent between
tions of the predicted sequence of hEST2 (Figures 1
telomerases and nontelomerase RTs, or alternatively,
and 2). Thus, the proposed human telomerase catalytic
nearly invariant among nontelomerase RTs but diver-subunit, like its yeast and ciliate counterparts, belongs
gent between these RTs and telomerases (Figure 2).to the RT superfamily of enzymes.
In summary, hEST2, Est2p, and p123 form a clearlyAlthough hEST2shares some sequence similarity with
defined subgroup within the RT family. For these rea-RTs, it is not a conventional RT. Rather, it is far more
sons, we conclude that hEST2 is a human homolog,closely related to the telomerase catalytic subunits of
and very likely an ortholog, of the microbial enzymesyeast and ciliates than to other RTs. Whereas the BLAST
described to date.probability of sequence similarity between hEST2 and
We mention in passing that our sequencing of a num-the telomerase subunits of the single-cell eukaryotes
ber of cDNA clones has revealed two distinct formsarising by chance is 10213±10218, the chance probability
of hEST2 transcripts. Four independent cDNA clones,of sequence similarity with the next most closely related
isolated from three independently generated librariesRT, a2-Sc, is 0.12. Beyond the motifs that define the
deriving from distinct cell types, lack an identical 182polymerase domains of these various enzymes, hEST2
bp segment within the open reading frame (data notshows no sequence similarity with RTs. In contrast, in its
shown). The absence of this segment leads to a shift indomains that lie N-terminal to the polymerase domain,
reading frame that introduces a premature terminationBLAST searches identify clear relatedness between
codon. Both forms of the hEST2 transcript were de-hEST2 and both p123 and Est2p, the chance occurrence
tected by RT±PCR in a variety of human cell types (dataof these similarities being 1.6 3 1029 and 1.8 3 1024,
not shown). Although we lack any information on therespectively. We note that many of the sequence identi-
intron-exon boundaries of hEST2, the simplest interpre-ties in the N termini of hEST2, p123, and Est2p reside
tation of these data is that the sequence difference be-in a region just before motif 1 (Figure 1, boxed region).
tween the two groups of cDNAs reflects the existenceThis sequence is not found in RTs, nor is it apparent in
of two alternatively spliced mRNAs of the hEST2 gene.other proteins, suggesting the presence of motifs that
The physiological consequences of the expression ofmay be unique to telomerases. Identification of the cata-
the potential nonfunctional hEST2 transcript are ob-lytic subunits of yet other telomerases will be required
to validate this possibility. scure at present.
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most common targets for amplification in non±small cell
lung cancers, being amplified in z70% of tumors
(Balsara et al., 1997; Petersen et al., 1997). The effects
of this amplification on hEST2 expression levels are un-
known.
Expression of hEST2 Transcripts
Much of our work has been motivated by the question
of how telomerase becomes activated during tumor pro-
gression. As discussed above, this activation has been
associated with the immortalization of tumor cells. A
variety of mechanisms might be invoked to explain such
activation, among which is the induction of the expres-
sion of one or more telomerase subunits. Since the telo-
merase holoenzyme is presumed to exist as a multisub-
unit ribonucleoprotein complex, the levels of any one of
the subunits, including those of the catalytic subunit
described here, might be rate-limiting in determing en-
zyme activity. Alternatively, the components of the telo-
merase holoenzyme might be expressed constitutively
and subject to various types of posttranslational modifi-
cation that would govern their activity. As mentionedFigure 3. Chromosomal Localization of hEST2
earlier, transcript levels of the telomerase RNA subunit
Ideogram of human chromosome 5p showing linkage of hEST2 to
and of the TP1/TLP1 gene do not necessarily correlatesequence-tagged site (STS) markers WI-9907 and D5S417 deter-
with telomerase activity (Feng et al., 1995; Avilion etmined by radiation hybrid mapping employing the Genebridge 4 RH
panel (GB) (1 cR 5 270 kb). The higher resolution Stanford G3 RH al., 1996; Blasco et al., 1996; Harrington et al., 1997;
panel (G3) placed hEST2 close to marker D5S678 (1 cR 5 30 kb). Nakayama et al., 1997), implying that at least one other
The calculated distance between hEST2 and these STS markers is mechanism is responsible for regulating human telo-
in centiRays (cR) with LOD scores in parentheses.
merase.
To address one of the remaining possible regulatory
mechanisms, we analyzed the expression levels ofChromosomal Localization of hEST2
The existing hEST2 cDNA was used as a probe in South- hEST2 mRNA in various cell types, using both RNA
Northern hybridizations and RNase protection assaysern blot analyses of human genomic DNA. These reveal
hEST2 to be a single-copy gene with an estimated size to do so. RNA blots prepared from a panel of normal
human tissues and human cancer cell lines were probedof 40 kb (data not shown). All of the genomic sequences
reactive with the cDNA probe appear to be components with cDNA fragments deriving from two independent,
nonoverlapping regions of the hEST2 gene. This probingof this z40 kb locus, suggesting that there are no other
closely related genes in the human genome. revealed two major RNA species migrating near the 4.4
kb and the 9.5 kb markers, as well as a minor specieshEST2was localized toa specific chromosomal region
by analyzing two independent panels of hamster-human of z6 kb (Figure 4). Each of these RNA species was
recognized by both probes, confirming that each repre-radiation hybrid (RH) cells with two markers spanning
different regions of hEST2. Initial mapping using the sents an hEST2 mRNA.
hEST2 message was detectable in several normal tis-Genebridge 4 RH panel placed both hEST2 markers
between sequence-tagged sites (STS) WI-9907 and sues including thymus, testis, and intestine. Of these,
testis (Kim et al., 1994; Wright et al., 1996) and intestineD5S417 (Figure 3). Independent confirmation of this lo-
calization was then obtained by mapping carried out (Hiyama et al., 1996) are known to be telomerase-posi-
tive, while the telomerase status of the thymus has notwith a second panel, the Stanford G3 RH panel. This
second mapping placed both hEST2 markers next to been reported. In marked contrast, the hEST2 transcript
was undetectable in our assays in most other normalSTS marker AFMA139YA9 (GDB locus D5S678), which
itself is localized between the above-mentioned markers human tissues, including heart, brain, placenta, liver,
skeletal muscle, and prostate (Figure 4), all of whichWI-9907 and D5S417. These markers are present at the
telomeric end of chromosome 5p (Hudson et al., 1995). have been reported to be telomerase-negative (Kim et
al., 1994; Wright et al., 1996; Shay and Bacchetti, 1997).Mapping of the hEST2 locus was further refined by
localizing it to subband 5p15.33, since the STS markers The absence of detectable hEST2 message inovary may
seem paradoxical, as ovary is a germline tissue andD5S678 and D5S417 have been assigned to this band
on the Genethon YAC contig map (Chumakov et al., germline tissues have been reported to harbor signifi-
cant levels of telomerase. However, oocyte division is1995). This localization is consistent with fluorescence
in situ hybridization (FISH) analysis of YAC 767E1. This completed by birth, and while fetal ovary is telomerase-
positive (Kim et al., 1994; Wright et al., 1996), both adultYAC maps further away from the telomere than D5S678
and has been assigned tochromosome 5p15.33 by FISH ovarian epithelium and mature oocytes are telomerase-
negative (Counter et al., 1994b; Wright et al., 1996). It(Chumakov et al., 1995).
We note in passing that chromosome 5p is one of the is also possible that the levels of hEST2 are below the
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Figure 4. Expression of hEST2 in Normal Hu-
man Tissues and Cancer Cell Lines
Duplicate RNA blots were probed with an
hEST2 probe (top panels) or with a b-actin
probe as internal control (bottompanels). The
4.4 kb, 6 kb, and 9.5 kb transcripts are hEST2-
specific.
threshold of detection. We note that the 7 kb band seen detectable levels of hEST2 RNA (Figure 5); two of the
colon tumors showed significantly elevated levels asin muscle tissue appears to be an artifact, as it was not
observed with an independent hEST2 probe (data not well. These data suggest that the hEST2 message is
expressed in a very high percentage of tumors and isshown).
In contrast to its absence in the majority of normal specifically induced in tumors that arise from telo-
merase-negative tissues.tissues, hEST2 mRNA was strongly expressed in a vari-
ety of cancer cell lines, most strikingly in the leukemic
cell lines HL-60 and K-562 (Figure 4). It is unclear why Up-Regulation of hEST2 mRNA Is Associated
with Telomerase Activation andonly very low levels of hEST2 message were observed
in HeLa cells on this particular Northern blot (Figure Cellular Immortalization
The strong expression of the hEST2 message observed4, rightmost panel, lane 2); reanalysis of independently
prepared HeLa cell RNA both by Northern blot and by in several tumors and cancer cell lines suggested that
the levels of this transcript might be correlated with theRNase protection demonstrated that hEST2 mRNA is
present in HeLa cells at high levels comparable to those amount of telomerase enzyme activity in these various
cell types. To investigate this possibility, we analyzedseen in K-562 cells (data not shown; Figure 6 below).
The two major and one minor hEST2 transcripts appear telomerase activity and hEST2 RNA level in a panel of
nonimmortalized and immortalized cell lines. Using theto be expressed in the same relative proportions in all
cell types that yielded detectable hEST2 mRNA. TRAP telomerase assay (Kim et al., 1994), two mortal
fibroblast strains, WI-38 and IMR-90, were found to lack
detectable telomerase activity, in contrast to three im-hEST2 Expression in Primary Human Cancers
The expression of hEST2 mRNA in cancer cell lines sug- mortal cell lines, HeLa, 293, and K-562, in which telo-
merase activity was readily detectable (Figure 6A). Thegested that hEST2 transcript levels might be elevated
in primary tumors as well. To test this, we extracted telomerase-negative cells also lackeddetectable hEST2
message as gauged by an RNase protection assay,RNA from a variety of tumor samples as well as from
normal control tissues and analyzed this RNA for the while the immortal telomerase-positive cell lines ex-
pressed significant levels of hEST2 RNA (Figure 6A).presence of hEST2 mRNA using an RNase protection
assay. In total, 11 of 11 tumor samples examined These results indicate that hEST2 message levels corre-
late closely with telomerase activity.showed detectable levels of hEST2 message (Figure
5). hEST2 RNA was undetectable in normal breast and The association between hEST2 RNA expression and
telomerase activity, both being present in immortalovarian tissue but was expressed at significant levels
in 2 of 2 breast tumors as well as 2 of 2 breast tumor± transformed cells but absent in mortal normal cells, sug-
gests that the induction of hEST2 expression might un-derived cell lines, and in 4 of 4 ovarian tumors.
As expected from Northern hybridization analysis of derlie the activation of telomerase that occurs during
cellular immortalization. As a direct test of this hypothe-hEST2 RNA (Figure 4) and the known pattern of telo-
merase catalytic activity in human tissues (Kim et al., sis, hEST2 transcript levels were analyzed by RNase
protection and were compared to the levels of hTR and1994; Hiyama et al., 1996), the hEST2 transcript was
detected at high levels by the RNase protection assay telomerase activity in precrisis cells prior to the up-
regulation of telomerase and in postcrisis telomerase-in testis and at moderate levels in colon. Similarly, using
the RNase protection assay, four colon tumor samples positive immortal cells from two different transformed
human cell populations: Epstein-Barr virus±transformedand a testicular tumor sample were found to express
Human Telomerase Catalytic Subunit
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Figure 5. hEST2 Expression in Primary Human Tumors
RNase protection assays are shown for hEST2 and b-actin controls. Sizes of the full-length and protected bands are indicated. Shown are
the HL-60 leukemia cell line (control), normal breast tissue, two primary breast tumors, the MCF7 and T47D breast cancer cell lines, and
normal and primary tumor tissues from the testis, colon, and ovary. The doublet seen protected by the hEST2 probe is invariant and may be
a result of probe secondary structure.
B lymphocytes (B4 cells) and SV40 T antigen±trans- previously reported (Avilion et al., 1996), the levels of
hTR remained essentially constant throughout the im-formed embryonic kidney cells (HA1 cells). As previously
described (Counter et al., 1992, 1994b; Avilion et al., mortalization process. The levels of hEST2 RNA, on the
other hand, parallel telomerase activity during cell im-1996), little or no telomerase activity was detected in
cells prior to crisis when telomere length decreases, but mortalization. hEST2 RNA was undetectable in the
precrisis cells but was clearly present in the postcri-abundant levels were detected in postcrisis cells that
maintain telomere length (Figure 6B). In contrast, as sis, telomerase-positive cells (Figure 6B). These results
Figure 6. Correlation in Cultured Cells of hEST2 RNA with Telomerase Activity and Immortalization Status
(A) Comparison of normal and immortalized cells. hEST2 and b-actin control RNA levels were determined by RNase protection analysis using
40 mg of total RNA from each cell type. Sizes of the full-length probes and protected fragments are indicated. Telomerase was assayed with
the TRAP protocol on 100 ng of cell lysate (bottom panel).
(B) Comparison of EBV-transformed B cells (B4) and SV40 T antigen±transformed kidney cells (HA1) precrisis and postcrisis. Cell line passage
numbers are indicated in parentheses. The top two panels show RNase protection of hEST2 and b-actin as a control. The third panel shows
Northern blot analysis of the hTR transcript. The bottom panel shows TRAP telomerase assays on 1 mg of cell lysate.
Cell
792
RNA species are under tight control in these cells. The
contrasting delay in the decline of telomerase activity
is consistent with the reported z24 hour half-life of the
enzymatic activity after cycloheximide treatment (Holt
et al., 1996).
Taken together, our findings suggest the possibility
that modulation of hEST2 RNA expression levels is an
important mechanism used in a variety of developmental
contexts to determine the amount of telomerase activity
present in specific cell lineages. Indeed, the levels of
the catalytic subunit of telomerase may represent a rate-
limiting determinant of enzyme activity in many types
of cells. Moreover, up-regulation of hEST2message may
be an important mechanism through which telomerase
becomes activated during both cellular immortalization
and the progression of malignant tumors.
Discussion
hEST2, the putative human telomerase subunit de-Figure 7. Changes in hEST2 RNA Expression during Induced Differ-
scribed here, shares extensive sequence similaritiesentiation of HL-60 Cells
with the catalytic subunits of the yeast and ciliate telo-Differentiation of the human promyelocytic leukemia cell line HL-60
was induced with all-trans retinoic acid as described in Experimental merase enzymes. The amino acid sequence conserva-
Procedures, and cells were collected for analysis at the indicated tion between these three enzymes is extensive and is
times. Total cellular RNA (20 mg) was analyzed for each time point. scattered throughout their reading frames. In addition,
The first three panels show RNase protection analysis of the hEST2,
we have been unable to detect related genes in the
b-actin control, and hTR transcripts, respectively. Analysis of the
human genome by Southern blotting analysis (nothuman b-actin transcript was performed in the same reaction tube
shown). Together, these data lead us to conclude thatas that for hEST2. The fourth panel shows Northern blot analysis of
the early growth response gene EGR-1, whose expression is rapidly the gene described here is very likely to specify the
induced during HL-60 differentiation (Nguyen et al., 1993); this is catalytic subunit of the human telomerase holoenzyme.
used as a control to verify cell differentiation. RNA quantity and Formal proof will depend upon experiments analogous
integrity were assessed by ethidium bromide staining (data not
to those performed with the yeast EST2 gene (Countershown).
et al., 1997; Lingner et al., 1997). Thus, such experiments
will need to demonstrate that mice lacking the mouse
strongly suggest that the induction of hEST2 message mEST2 homolog also lack telomerase activity; that the
may be a rate-limiting step for the activation of telo- hEST2 protein is physically associated with a ribo-
merase during immortalization. nucleoprotein complex that exhibits telomerase activity;
and that alteration of critical residues in the domain of
Down-Regulation of hEST2 Expression hEST2 that is homologous toRTs inactivates its catalytic
upon Cellular Differentiation function.
Since the up-regulation of hEST2 RNA is associated While all three telomerases described to date give
with the activation of telomerase duringcell immortaliza- indications of being distant homologs of a variety of
tion, we wondered whether conditions that repress telo- RTs, they also share several unique, telomerase-specific
merase activity in cultured cells might similarly operate sequence motifs. Because yeast, ciliates, and mammals
by shutting down expression of the hEST2 mRNA in represent highly diverged branches of the phylogenetic
these cells. Human HL-60 promyelocytic leukemia cells tree, this suggests that the catalytic subunit of the telo-
can be induced to differentiate to mature granulocytes merase was developed early in eukaryotic evolution,
by treatment with retinoic acid. During this process, being present possibly in the cell that became ancestral
telomerase activity has been shown to decline over a to all contemporary eukaryotes. Further back, it appears
period of 2±5 days (Sharma et al., 1995; Bestilny et al., that this enzyme shares ancestry with the precursors
1996; Savoysky et al., 1996; Xu et al., 1996). of the RTs specified by a variety of transposons and
As demonstrated inFigure 7, inductionof HL-60 differ- viruses.
entiation leads to the disappearance of thehEST2 mRNA The repression of hEST2 mRNA in telomerase-nega-
within 24 hours, foreshadowing the loss of telomerase tive cells and tissues and its up-regulation that is associ-
activity that declines more slowly. Once again, this con- ated here with a number of human tumor cell lines and
trasts with the behavior of the human telomerase RNA primary human tumors suggest one mechanism by
subunit, whose expression during induced differentia- which telomerase activity might be modulated. During
tion remains constant (Figure 7) as previously reported development, the expression of the hEST2 mRNA may
(Bestilny et al., 1996). We note that the levels of the be repressed in many postembryonic cell lineages, de-
hEST2 mRNA decline precipitously within the first 3 priving cells in these lineages of the telomerase catalytic
hours after induced differentiation. This rapid down- subunit. This in turn may underlie the observed progres-
modulation is compatible with a short half-life for the sive telomeric shortening associated with aging in the
cells in many of these lineages.hEST2 message and suggests that the levels of this
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the 59-most 500 bp region identified from the hEST2 cDNA clonesIn contrast, the reappearance of telomerase enzyme
yielded one new clone containing an insert that overlapped withactivity when transformed cells escape from crisis or
already determined sequences.when tumors progress toward malignancy may in many
Rapid amplification of cDNA ends (RACE) was performed by PCR
cases be explained mechanistically by the derepression amplifying testis Marathon-ready cDNA (Clontech, Palo Alto, CA)
of hEST2 mRNA expression. As reported here, in cell with flanking primer AP-1 (Clontech) and hEST2 primer R0096 (59-CA
AGAAACCCACGGTCACTCGGTCCACGCG-39), and then reampli-cultures, this derepression occurs in both transformed
fying with flanking primer AP-2 and hEST2 primer R0098 (59-CAGCTembryonic kidney cells and lymphocytes when they
CCTTCAGGCAGGACACCTGCGGG-39). The product was subclonedemerge fromcrisis and begin toexhibit telomeraseactiv-
and sequenced in both directions. RACE was also performed onity. Our work does not address whether the enhanced
aliquoted pools of plasmid DNA from a human testis cDNA library
hEST2 RNA expression is achieved at the transcriptional (Reduced Complexity cDNA Analysis, Q. L. and Fang Chen, unpub-
or posttranscriptional level. lished data) with primers HT-21 (59-CAGGTGACACCACACAG
AAA-39) or HT-22 (59-TTCCAAGCAGCTCCAGAAA-39) and a vectorAlthough we have found a general correlation between
primer, reamplified with the vector primer and hEST2 primers R0098hEST2 mRNA levels and assayable telomerase activity,
or R0097 (59-CCTTCGGGGTCCACTAGCGTGTGGCGG), then puri-the present experiments do not demonstrate that these
fied and sequenced.two manifestations of hEST2 gene expression are al-
DNA sequencing reactions were performed with the AmpliTaq FS
ways present in some constant, predictable ratio. This Prism ready reaction cycle sequencing kit (Perkin-Elmer/ABI) and
leaves open the possibility that other mechanisms be- electrophoresed on a 373 A Stretch ABI DNA sequencer. The re-
sulting sequences were assembled into a contig using the programsides the presently observed modulation of hEST2
Sequencher 3.0 (Gene Codes Corporation, Ann Arbor, MI). The 1132mRNA levels may intervene to modulate telomerase ac-
amino acid ORF identified in this contig was aligned with p123 andtivity.
Est2p using the Pattern-Induced Multi-Sequence Alignment Pro-Perhaps most important, the identification of hEST2
gram version 1.4 (R. F. Smith, Baylor College of Medicine, and T. F.
as the gene specifying the putative telomerase catalytic Smith, Boston University), with minor modifications to the final align-
subunit may provide an entree into understanding one of ment. BLASTP searches were performed against the nonredundant
the essential steps in human tumor pathogenesisÐthat protein databases.
leading to cell immortalization. Enzymatic assays have
Radiation Hybrid Mappingdemonstrated that telomerase is often activated at a
Genomic DNA (25 ng) from hybrid clones of the Genebridge 4 andrelatively late step in tumor progression (Harley et al.,
Stanford G3 radiation hybrid (RH) mapping panels (Research Genet-1994). This step may occur when evolving, premalignant
ics, Inc. Huntsville, AL) was PCR-amplified with the primer pair M1
cell clones have surmounted the senescence barrier and (forward-59-CACAGCCAGGCCGAGAGCAGA-39 and reverse-59-AGG
subsequently, having exhausted their telomeric ends, CCTCAGCCGGACACTCAG-39), yielding a 170 bp fragment in the
encounter the successive barrier of crisis. At this stage, 39-untranslated region, and with primer pair M2 (forward-59-GAAGA
AAACATTTCTGTCGTG-39 and reverse-59-GCCCTTGGCCCCCAGCthe activation of telomerase may enable cells to breach
GACAT-39), generating a 180bp fragment crossing a putative intron-these barriers to further clonal expansion, thereby con-
exon boundary near the hEST2 stop codon. PCR was carried outferring great selective advantage on the rare cell that
for 35 cycles of 948C for 0.5 min, 698C for M1 or 658C for M2 for 0.5
has acquired the ability to resurrect the long-repressed min, and 728C for 1.5 min. The results of the PCR screening were
telomerase activity. Indeed, activation of telomerase analyzed using the statistical program RHMAP (Hudson et al., 1995;
may represent an essential step in tumor progression. Stewart et al., 1997). STS markers were linked to both a physical
chromosomal map and to YACs physically mapped by FISH (CohenSuch dependence on telomerase activity would sug-
et al., 1993; Chumakov et al., 1995; Hudson et al., 1995).gest that this enzyme represents an attractive target of
drugs designed to interfere with malignant cell prolifera-
RNA Isolation from Cell Lines and Primary Tissuestion. The finding that hEST2 message is up-regulated
Cell lines were obtained from the American Type Culture Collection
in human tumors and in immortalized cells lends further and grown under standard conditions. For HL-60 differentiation
credence to this idea. Furthermore, the identification of assays, cells were pelleted and resuspended in normal growth me-
hEST2 as the candidate telomerase catalytic subunit dium plus all-trans retinoic acid (Sigma) at a final concentration of
1 mM.may provide a biochemical reagent for identifying such
All primary normal and tumor tissues were obtained from thedrugs.
Massachusetts General Hospital tumor bank. Tissues were pro-
cessed in a tissue homogenizer. RNA samples were prepared in theExperimental Procedures
RNA Stat-60 solution (Tel-Test ªB,º Friendswood, Texas) according
to the manufacturer's protocol.Cloning of hEST2
The expressed sequence tag database (dbEST) was searched for
Northern Hybridizationsequences related to the yeast protein Est2p (Lendvay et al., 1996)
Duplicate filters containing poly A(1)-selected mRNAs from variousand the Euplotes protein p123 (Lingner et al., 1997), using the pro-
human tissues and cell lines (Multiple Tissue Northern Blots, Clon-gram TBLASTN. This resulted in the identification of a homologous
tech, Palo Alto, CA),were incubated according to the manufacturer'sexpressed sequence tag, GenBank accession number AA281296,
instructions with two independent hEST2 probes. One probe waswhich derived from Soares NbHTGBC cDNA clone 712562. DNA
derived by PCR-amplifying plasmid 712562 with primers HT-1 andfrom clone plasmid 712562 was PCR-amplified with primers HT-1
HT-5 to generate the 377 bp fragment described above; the second,(59-AAGTTCCTGCACTGGCTGATGAG-39) and HT-5 (59-TCGTAGTT
more 39 probe was generated from the 1064 bp StuI fragment ofGAGCACGCTGAACAG-39). The resulting 377 bp fragment was used
the same plasmid. The duplicate blots were then rehybridized withto probe l ZAP phage cDNA libraries derived from the human Jurkat
a b-actin probe. Northern blots for detection of hTR were performedT-cell lymphoma(Stratagene, La Jolla, CA) and human Nalm-6 pre-B
with total RNA and an hTR-specific probe (Feng et al., 1995).cell leukemia cell lines (Weissbach et al., 1994). A total of seven
independent clones were isolated from these two libraries. Three
RNAse Protection Analysisof these cDNAclones togetherwith plasmid 712562 weresequenced
Radiolabelled RNA probes for RNAse protection analysis were syn-completely in both directions. The remaining clones were se-
quenced in specific regions. Reprobing of the Jurkat library with thesized using [a-32P]UTP, T7 RNA polymerase, and the MAXIscript
Cell
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kit (Ambion, Austin, TX). DNA templates for probe synthesis were Chumakov, I.M., Rigault, P., Le Gall, I., Bellanne-Chantelot, C., Bil-
lault, A., Guillou, S., Soularue, P., Guasconi, G., Poullier, E., Gros,created as follows. For the hEST2 probe, the insert from plasmid
I., et al. (1995). A YAC contig map of the human genome. Natureclone 712562 was subcloned into pUHD 1023 (a gift from M. Gossen),
377, 175±297.and template DNA was synthesized by PCRusing a forward plasmid-
specific primer and a reverse primer containing 18 bp of hEST2 Cohen, D., Chumakov, I., andWeissenbach, J. (1993). A first-genera-
complementary sequence (59-TCTCTGCGGAAGTTCTG) and the T7 tion physical map of the human genome. Nature 366, 698±701.
promoter sequence. For the b-actin probe, template DNA was syn- Cohn, M., and Blackburn, E.H. (1995). Telomerase in yeast. Science
thesized by PCR on a human b-actin cDNA insert (Clontech). The 269, 396±400.
hEST2 and the b-actin control probes were hybridized in the same
Collins, K., Kobayashi, R., and Greider, C.W. (1995). Purification ofreaction tube. The hTR probe was synthesized directly from the
Tetrahymena telomerase and cloning of genes encoding the twolinearized pGRN83 plasmid (Feng et al., 1995).
protein components of the enzyme. Cell 81, 677±686.RNase protection analysis was performed using the HybSpeed
Counter, C.M., Avilion, A.A., Le Feuvre, C.E., Stewart, N.G., Greider,RPA kit (Ambion) according to the manufacturer's protocol. Briefly,
C.W., Harley, C.B., and Bacchetti, S. (1992). Telomere shorteningsample RNA and radiolabeled RNA probes were coprecipitated in
associated with chromosome instability is arrested in immortal cellsethanol, resuspended in hybridization buffer, hybridized at 688C,
which express telomerase activity. EMBO J. 11, 1921±1929.then digested with RNases A and T1. Samples were then reprecipi-
Counter, C.M., Botelho, F.M., Wang, P., Harley, C.B., and Bacchetti,tated and analyzed on a 6% denaturing polyacrylamide gel.
S. (1994a). Stabilization of short telomeres and telomerase activity
accompany immortalization of Epstein-Barr virus-transformed hu-
Telomerase Assays
man B lymphocytes. J. Virol. 68, 3410±3414.
Telomerase repeat amplification protocol (TRAP) assays were per-
Counter, C.M., Hirte, H.W., Bacchetti, S., and Harley, C.B. (1994b).formed as described (Kim et al., 1994), in some cases using the
Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad.TRAPeze telomerase detection kit (Oncor, Gaithersburg, MD).
Sci. USA 91, 2900±2904.
Counter, C.M., Gupta, J., Harley, C.B., Leber, B., and Bacchetti, S.
Acknowledgments (1995). Telomerase activity in normal leukocytes and in hematologic
malignancies. Blood 85, 2315±2320.
We are grateful to members of the Weinberg laboratory for help,
Counter, C.M., Meyerson, M., Eaton,E.N., and Weinberg, R.A. (1997).advice, and encouragement, and to A. Tidy and V. Leong (McMaster
The catalytic subunit of yeast telomerase. Proc. Natl. Acad. Sci.University) for technical assistance. This work was supported by
USA 94, 9202±9207.grants from the National Cancer Institute of the USA (CA 58596 to
Feng, J., Funk, W.D., Wang, S.S., Weinrich, S.L., Avilion, A.A., Chiu,D. A. H. and OIG CA 39826 to R. A. W.) and from the National Cancer
C.P., Adams, R.R., Chang, E., Allsopp, R.C., Yu, J., et al. (1995). TheInstitute of Canada (NCIC) (#7182 to S. B.). M. M. is supported by
RNA component of human telomerase. Science 269, 1236±1241.the Damon Runyon-Walter Winchell Cancer Research Foundation;
Goldstein, S. (1990). Replicative senescence: the human fibroblastC. M. C. by the NCIC and the MIT-Merck postdoctoral fellowship;
comes of age. Science 249, 1129±1133.L. W. E. by the Howard Hughes Medical Institute; and P. S. and
R. L. B. by the Human Frontier Science Program. S. B. is a Terry Gollahon, L.S., and Shay, J.W. (1996). Immortalization of human
Fox Cancer Research Scientist of the NCIC. R. A. W. is an American mammary epithelial cells transfected with mutant p53 (273his). On-
Cancer Society Research Professor and a Daniel K. Ludwig Cancer cogene 12, 715±725.
Research Professor. Greider, C.W. (1995). Telomerase biochemistry and regulation. In
Telomeres, E.H. Blackburn and C.W. Greider, eds. (Cold Spring Har-
bor, NY: Cold Spring Harbor Laboratory Press), pp. 35±68.Received July 15, 1997; revised July 31, 1997.
Greider, C.W., and Blackburn, E.H. (1985). Identification of a specific
telomere terminal transferase activity in Tetrahymena extracts. CellReferences
43, 405±413.
Greider, C.W., and Blackburn, E.H. (1989). A telomeric sequence inAvilion, A.A., Piatyszek, M.A., Gupta, J., Shay, J.W., Bacchetti, S.,
the RNA of Tetrahymena telomerase required for telomere repeatand Greider, C.W. (1996). Human telomerase RNA and telomerase
synthesis. Nature 337, 331±337.activity in immortal cell lines and tumor tissues. Cancer Res. 56,
645±650. Harley, C.B., Futcher, A.B., and Greider, C.W. (1990). Telomeres
shorten during ageing of human fibroblasts. Nature 345, 458±460.Balsara, B.R., Sonoda, G., du Manoir, S., Siegfried, J.M., Gabrielson,
E., and Testa, J.R. (1997). Comparative genomic hybridization analy- Harley, C.B., Kim, N.W., Prowse, K.R., Weinrich, S.L., Hirsch, K.S.,
sis detects frequent, often high-level, overrepresentation of DNA West, M.D., Bacchetti, S., Hirte, H.W., Counter, C.M., Greider, C.W.,
sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carci- et al. (1994). Telomerase, cell immortality, and cancer. Cold Spring
Harb. Symp. Quant. Biol. 59, 307±315.nomas. Cancer Res. 57, 2116±2120.
Harrington, L., McPhail, T., Mar, V., Zhou, W., Oulton, R., Program,Bestilny, L.J., Brown, C.B., Miura, Y., Robertson, L.D., and Riabowol,
A.E., Bass, M.B., Arruda, I., and Robinson,M.O. (1997). A mammalianK.T. (1996). Selective inhibition of telomerase activity during terminal
telomerase-associated protein. Science 275, 973±977.differentiation of immortal cell lines. Cancer Res. 56, 3796±3802.
Hastie, N.D., Dempster, M., Dunlop, M.G., Thompson, A.M., Green,Blackburn, E.H. (1984). The molecular structure of centromeres and
D.K., and Allshire, R.C. (1990). Telomere reduction in human colo-telomeres. Annu. Rev. Biochem. 53, 163±194.
rectal carcinoma and with ageing. Nature 346, 866±868.Blackburn, E.H. (1991). Structure and function of telomeres. Nature
Hayflick, L., and Moorhead, P.S. (1961). The serial cultivation of350, 569±573.
human diploid cell strains. Exp. Cell. Res. 25, 585±621.Blasco, M.A., Rizen, M., Greider, C.W., and Hanahan, D. (1996).
Hiyama, E., Hiyama, K., Tatsumoto, N., Kodama, T., Shay, J.W., andDifferential regulation of telomerase activity and telomerase RNA
Yokoyama, T. (1996). Telomerase activity in human intestine. Int. J.during multi-stage tumorigenesis. Nat. Genet. 12, 200±204.
Oncol. 9, 453±458.Broccoli, D., Godley, L.A., Donehower, L.A., Varmus, H.E., and de
Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatys-Lange, T. (1996). Telomerase activation in mouse mammary tumors:
zek, M.A., Shay, J.W., Ishioka, S., and Yamakido, M. (1995). Activa-lack of detectable telomere shortening and evidence for regulation
tion of telomerase in human lymphocytes and hematopoietic pro-of telomerase RNA with cell proliferation. Mol. Cell. Biol. 16, 3765±
genitor cells. J. Immunol. 155, 3711±3715.3772.
Holt, S.E., Wright, W.E., and Shay, J.W. (1996). Regulation of telo-Broccoli, D., Young, J.W., and de Lange, T. (1995). Telomerase activ-
merase activity in immortal cell lines. Mol. Cell. Biol. 16, 2932±2939.ity in normal and malignant hematopoietic cells. Proc. Natl. Acad.
Sci. USA 92, 9082±9086. Hudson, T.J., Stein, L.D., Gerety, S.S., Ma, J., Castle, A.B., Silva, J.,
Human Telomerase Catalytic Subunit
795
Slonim, D.K., Baptista, R., Kruglyak, L., Xu, S.H., et al. (1995). An Shay, J.W., Wright, W.E., Brasiskyte, D., and Van der Haegen, B.A.
(1993). E6 of human papillomavirus type 16 can overcome the M1STS-based map of the human genome. Science 270, 1945±1954.
stage of immortalization in human mammary epithelial cells but notHuschtscha, L.I., and Holliday, R. (1983). Limited and unlimited
in human fibroblasts. Oncogene 8, 1407±1413.growth of SV40-transformed cells from human diploid MRC-5 fibro-
blasts. J. Cell Sci. 63, 77±99. Singer, M.S., and Gottschling, D.E. (1994). TLC1: template RNA com-
ponent of Saccharomyces cerevisiae telomerase. Science 266,Kennell, J.C., Moran, J.V., Perlman, P.S., Butow, R.A., and Lambo-
404±409.witz, A.M. (1993). Reverse transcriptase activity associated with
maturase-encoding group II introns in yeast mitochondria. Cell 73, Soder, A.I., Hoare, S.F., Muir, S., Going, J.J., Parkinson, E.K., and
Keith, W.N. (1997). Amplification, increased dosage and in situ ex-133±146.
pression of the telomerase RNA gene in human cancer. OncogeneKim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D.,
14, 1013±1021.Ho, P.L., Coviello, G.M., Wright, W.E., Weinrich, S.L., and Shay,
J.W. (1994). Specific association of human telomerase activity with Stewart, E.A., McKusick, K.B., Aggarwal, A., Bajorek, W., Brady, S.,
Chu, A., Fang, N., Hadley, D., Harris, M., Hussain, S., et al. (1997).immortal cells and cancer. Science 266, 2011±2015.
An STS-based radiation hybrid map of the human genome. GenomeKlingelhutz, A.J., Barber, S.A., Smith, P.P., Dyer, K., and McDougall,
Res. 7, 422±433.J.K. (1994). Restoration of telomeres in human papillomavirus-
immortalized human anogenital epithelial cells. Mol. Cell. Biol. 14, Watson, J.D. (1972). Origin of concatemeric T7 DNA. Nat. New Biol.
239, 197±201.961±969.
Klingelhutz, A.J., Foster, S.A., and McDougall, J.K. (1996). Telo- Weissbach, L., Settleman, J., Kalady, M.F., Snijders, A.J., Murthy,
A.E., Yan, Y.X., and Bernards, A. (1994). Identification of a humanmerase activation by the E6 gene product of human papillomavirus
type 16. Nature 380, 79±82. rasGAP-related protein containing calmodulin-binding motifs. J.
Biol. Chem. 269, 20517±20521.Kozak, M. (1986). Point mutations define a sequence flanking the
AUG initiator codon that modulates translation by eukaryotic ribo- Whitaker, N.J., Bryan, T.M., Bonnefin, P., Chang, A.C., Musgrove,
E.A., Braithwaite, A.W., and Reddel, R.R. (1995). Involvement ofsomes. Cell 44, 283±292.
RB-1, p53, p16INK4 and telomerase in immortalisation of humanLendvay, T.S., Morris, D.K., Sah, J., Balasubramanian, B., and Lund-
cells. Oncogene 11, 971±976.blad, V. (1996). Senescence mutants of Saccharomyces cerevisiae
with a defect in telomere replication identify three additional EST Wright, W.E., Piatyszek, M.A., Rainey, W.E., Byrd, W., and Shay,
J.W. (1996). Telomerase activity in human germline and embryonicgenes. Genetics 144, 1399±1412.
tissues and cells. Dev. Genet. 18, 173±179.Lingner, J., Hughes, T.R., Shevchenko, A., Mann, M., Lundblad, V.,
and Cech, T.R. (1997). Reverse transcriptase motifs in the catalytic Xiong, Y., and Eickbush, T.H. (1990). Origin and evolution of retroele-
ments based upon their reverse transcriptase sequences. EMBO J.subunit of telomerase. Science 276, 561±567.
9, 3353±3362.McEachern, M.J., and Blackburn, E.H. (1995). Runaway telomere
elongation caused by telomerase RNA gene mutations. Nature 376, Xu, D., Gruber, A., Peterson, C., and Pisa, P. (1996). Suppression of
telomerase activity in HL60 cells after treatment with differentiating403±409.
agents. Leukemia 10, 1354±1357.Nakayama, J.-i., Saito, M., Nakamura, H., Matsuura, A., and Ishi-
kawa, F. (1997). TLP1: a gene encoding a protein component of Yu, G.L., and Blackburn, E.H. (1991). Developmentally programmed
healing of chromosomes by telomerase in Tetrahymena. Cell 67,mammalian telomerase is a novel member of WD repeats family.
Cell 88, 875±884. 823±832.
Yu, G.L., Bradley, J.D., Attardi, L.D., and Blackburn, E.H. (1990). InNguyen, H.Q., Hoffman-Liebermann, B., and Liebermann, D.A.
(1993). The zinc finger transcription factor Egr-1 is essential for vivo alteration of telomere sequences and senescence caused by
mutated Tetrahymena telomerase RNAs. Nature 344, 126±132.and restricts differentiation along the macrophage lineage. Cell 72,
197±209. Zakian, V.A. (1995). Telomeres: beginning to understand the end.
Science 270, 1601±1607.Olovnikov, A.M. (1971). [Principle of marginotomy in template syn-
thesis of polynucleotides]. Dokl. Akad. Nauk SSSR 201, 1496±1499.
GenBank Accession NumberPetersen, I., Bujard,M., Petersen,S., Wolf, G., Goeze,A., Schwendel,
A., Langreck, H., Gellert, K., Reichel, M., Just, K., et al. (1997). Pat-
The accession number for the cDNA sequence of hEST2 reportedterns of chromosomal imbalances in adenocarcinoma and squa-
in this paper is AF018167.mous cell carcinoma of the lung. Cancer Res. 57, 2331±2335.
Poch, O., Sauvaget, I., Delarue, M., and Tordo, N. (1989). Identifica-
Note Added in Prooftion of four conserved motifs among the RNA-dependent polymer-
ase encoding elements. EMBO J. 8, 3867±3874.
As a clarification, we note that the initial TBLASTN search that
Sack, G.H., Jr. (1981). Human cell transformation by simian virus identified the hEST2 expressed sequence tag was performed with
40Ða review. In Vitro 17, 1±19. the Euplotes p123 protein (Lingner et al., 1997). Comparison with
Savoysky, E., Yoshida, K., Ohtomo, T., Yamaguchi, Y., Akamatsu, the yeast Est2p sequence (Lendvay et al., 1996) was used to confirm
K., Yamazaki, T., Yoshida, S., and Tsuchiya, M. (1996). Down-regula- the significance of this homology.
tion of telomerase activity is an early event in the differentiation of
HL60 cells. Biochem. Biophys. Res. Commun. 226, 329±334.
Sharma, H.W., Sokoloski, J.A., Perez, J.R., Maltese, J.Y., Sartorelli,
A.C., Stein, C.A., Nichols, G., Khaled, Z., Telang, N.T., and Naraya-
nan, R. (1995). Differentiation of immortal cells inhibits telomerase
activity. Proc. Natl. Acad. Sci. USA 92, 12343±12346.
Shay, J.W., and Bacchetti, S. (1997). A survey of telomerase activity
in human cancer. Eur. J. Cancer 33, 787±791.
Shay, J.W., Tomlinson, G., Piatyszek, M.A., and Gollahon, L.S.
(1995). Spontaneous in vitro immortalization of breast epithelial cells
from a patient with Li-Fraumeni syndrome. Mol. Cell. Biol. 15,
425±432.
Shay, J.W., and Wright, W.E. (1989). Quantitation of the frequency
of immortalization of normal human diploid fibroblastsby SV40 large
T-antigen. Exp. Cell Res. 184, 109±118.
